Barnetson R S, Marley J, Bullen M, Brookman S, Cowen P, Ellis D, Williams T
Department of Dermatology, Royal Prince Alfred Hospital, NSW, Australia.
Br J Dermatol. 1998 Oct;139(4):675-8. doi: 10.1046/j.1365-2133.1998.02466.x.
Treatment of interdigital tinea pedis often involves long-term therapy with topically applied preparations. Effective oral preparations, such as the allylamine terbinafine (Lamisil), taken over a shorter period, could provide a useful therapeutic alternative. A total of 269 patients from five centres with clinically diagnosed interdigital tinea pedis were entered into this double-blind, randomized, double-dummy, parallel-group study comparing oral terbinafine 250 mg once daily for 1 week with 1% clotrimazole (Canesten) cream applied twice daily for 4 weeks. Of these, 137 patients were evaluable for efficacy (confirmed dermatophyte infection by microscopy and culture): 63 terbinafine and 74 clotrimazole. At week 4, the mycological cure rates (negative culture at week 1 and negative results on microscopy and culture at week 4 onwards) were very similar (71% for clotrimazole and 72% for terbinafine). There was a faster response rate in the terbinafine group with respect to signs and symptoms at week 1. Both treatments were equally well tolerated; adverse events occurred equally in the two groups. In conclusion, oral terbinafine in a single daily dose of 250 mg for 1 week is as effective and as well tolerated as 1% clotrimazole cream applied twice daily for 4 weeks in the treatment of interdigital tinea pedis.
足趾间足癣的治疗通常需要长期外用制剂治疗。有效的口服制剂,如在较短时间内服用的烯丙胺类特比萘芬(兰美抒),可提供一种有用的治疗选择。来自五个中心的总共269例临床诊断为足趾间足癣的患者进入了这项双盲、随机、双模拟、平行组研究,比较每日一次口服250mg特比萘芬,连用1周与每日两次外用1%克霉唑(凯妮汀)乳膏,连用4周的疗效。其中,137例患者可进行疗效评估(通过显微镜检查和培养确诊为皮肤癣菌感染):63例使用特比萘芬,74例使用克霉唑。在第4周时,真菌学治愈率(第1周培养阴性,第4周及以后显微镜检查和培养结果均为阴性)非常相似(克霉唑为71%,特比萘芬为72%)。特比萘芬组在第1周时症状和体征的缓解速度更快。两种治疗的耐受性相当;两组不良事件的发生率相同。总之,每日单次口服250mg特比萘芬,连用1周在治疗足趾间足癣方面与每日两次外用1%克霉唑乳膏,连用4周一样有效且耐受性良好。